Exosome therapy for facial skin aging
Part of Skin clinical trials.
This trial tests if injections of exosomes from stem cells can improve facial skin quality. It may be a good option if you are between 18 and 65, have visible aging signs, and have not had recent cosmetic treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have visible signs of aging on your face
- You are willing to get three injections in your face
- You can attend all study visits and follow instructions
- You do not have active skin infections or open wounds on your face
- You have not used certain medications (retinoids) in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests whether injections of a substance called secretome can improve facial aging by reducing wrinkles and improving skin elasticity and texture. Participants receive multiple injections over several visits and must be willing to follow a strict skincare routine and avoid other cosmetic procedures during the study.
This study tests whether a new aesthetic device called Cellbooster Shape can safely reduce signs of facial aging, like loose skin and puffiness under the chin or cheeks, in healthy adults. The device uses a procedure similar to other cosmetic treatments.
This study tests an oral supplement to see if it improves signs of facial skin aging in healthy adults. Participants take the supplement daily for 8 weeks and undergo two small skin biopsies on the upper arms to measure changes.
This study tests whether a collagen serum, alone or with a skin-stimulating procedure called Radiesse, works better for aged skin. It looks at wrinkles, skin glow, and fullness.
This trial tests a new treatment called exosomes (tiny particles from cells) to improve the appearance of multiple atrophic scars on the face. Atrophic scars are indented or sunken scars. The study aims to see if exosomes can help smooth and improve how these scars look.
This trial tests whether stem cell exosomes, combined with laser or microneedle treatments, can improve melasma (dark patches on the face). It aims to find a better way to lighten these spots.
Hear when a new Skin Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.